Navigation Links
Ginger Offers Hope In Ovarian Cancer Fight

A recent study conducted by researchers at University of Michigan has showed that ginger can kill cancer cells//, the results of which were presented at the American Association of Cancer Research. Additionally, it was also found to prevent the development of drug resistance, a phenomenon that makes cancers difficult to treat.

This study highlights that a commonly used spice, ginger could be used in the development of a new drug for cancer treatment. More research is needed however, to substantiate the above findings. Previous studies have already established that ginger has anti-inflammatory properties and can ease nausea.

The researchers applied the commercially available ginger powder, dissolved in a solution to ovarian cancer cells, extracted from cancer patients. All the tests done, revealed that ginger was effective in killing cancer cells. The ginger solution was found to induce a two-way death, one apoptosis (programmed cell death) and autophagy (cell death due to self-digestion).

'Most ovarian cancer patients develop recurrent disease that eventually becomes resistant to standard chemotherapy, which is associated with apoptosis. If ginger can cause autophagic cell death in addition to apoptosis, it may circumvent resistance to conventional chemotherapy,' said Rebecca Liu, report author.

This promising research offers a new ray of hope to cancer patients. The distinct advantage of this treatment the relatively low risk of side effects and the ease of administering the spice in the form of a capsule. The researchers have at this juncture pointed out to the fact that the research is very preliminary and have warned about using this technique without extensive testing and approval.

'This study doesn't mean that people should dash down to the supermarket and stockpile ginger. We still don't know whether ginger, in any form, can prevent or treat cancers in animals or people,' warned Henry Scowcroft, of Cancer Res earch UK.


'"/>




Related medicine news :

1. Ginger to reduce nausea for pregnant women
2. Ginger Found To Reduce Nausea Associated With Chemotherapy
3. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
4. Drug Offers Hope for Alzheimers disease
5. Drug Firm Offers to Donate Smallpox Vaccine
6. fMRI Offers Insight Into An Infants Brain
7. Gel Offers A More Targeted Approach
8. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
9. Surgery Offers Better Treatment For Third Degree Piles
10. New Study Offers Hope For Balding Men
11. Gamma Knife Offers New Hope For Trigeminal Neuralgia Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... ... February 18, 2017 , ... ... the latest information and contact points to easily connect elderly veterans of America's ... living, and elder-care funding. It also conveys material on this year's increase in ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
(Date:2/17/2017)... Austin, Tx (PRWEB) , ... February 17, 2017 ... ... of revenue cycle management services, announced today that Karen Pilley has been promoted ... expenses is critical in today’s shifting healthcare paradigm – a shift that demands ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 According to a new market ... Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End ... by MarketsandMarkets, the market is expected to reach USD 330.6 Million ... of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... , Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: ... U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine ... Hydrocodone bitartrate and homatropine methylbromide oral solution ... the symptomatic relief of cough in adults and children 6 ... months ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017   ... other side effects allegedly associated with use of the ... Philadelphia Court of Common Pleas, ... a mass tort program. According to a notice posted ... scheduled to convene a meeting on March 9, 2017 ...
Breaking Medicine Technology: